Clostridioides difficile
Anaerobic, Gram-positive, spore-forming, toxin-producing bacillus that is the leading cause of healthcare-associated antibiotic-related diarrhea and pseudomembranous colitis.
Organism Card
| Domain | Must know |
|---|---|
| Identity |
|
| Lab discriminator |
|
| Reservoir / transmission |
|
| Key virulence |
|
| Clinical syndromes |
|
| Diagnosis |
|
| Treatment |
|
| Prevention |
|
| Classic traps |
|
Exam Intelligence
-
GC 099 (Antimicrobial Resistance) & GC 106 (Practical Issues in Antibiotic Use): C. difficile is the paradigm organism for antibiotic stewardship — exam questions frequently frame it as the consequence of inappropriate broad-spectrum antibiotic use [1]. The lecture emphasis is that clindamycin, fluoroquinolones, and third-generation cephalosporins are the highest-risk antibiotics for triggering CDI.
-
GC 104 (Infection Outbreak / Infection Control): C. difficile is a key healthcare-associated infection requiring contact precautions, soap-and-water hand hygiene, and environmental decontamination with sporicidal agents (bleach) [1]. Alcohol gel inefficacy is a favourite MCQ discriminator.
-
GC 102 (Fever After Chemotherapy / Immunocompromised Hosts): In the post-chemotherapy neutropenic patient with diarrhoea, C. difficile must be excluded as a cause — stool toxin assay is mandatory [1]. The 2021 SAQ Q12 (see below) directly tests organisms causing diarrhoea post-bone-marrow transplant, where C. difficile is a key answer.
-
CFB WCS27 (Surgical Infection): pseudomembranous colitis and toxic megacolon are surgical emergencies; colectomy may be needed for fulminant C. difficile colitis [1].
-
AOS Microbiology: C. difficile toxin detection algorithm (GDH screen → toxin EIA/PCR) is high-yield for diagnostic questions [2]. Emphasise that testing should only be done on unformed stool and test-of-cure is not recommended.
-
GC 033 (Chronic Diarrhoea / IBD) and GC 142 (A Child with Loose Stool): C. difficile should be considered in the differential of chronic/relapsing diarrhoea especially in patients with recent antibiotic exposure or hospitalisation [1]. In paediatric settings, note that neonates/infants < 12 months can be asymptomatically colonised — testing is generally not recommended in this age group.
- Alcohol hand-rub vs soap-and-water: The single most tested infection control point for C. difficile. Spores are resistant to alcohol. Always choose soap-and-water.
- Metronidazole vs vancomycin: Older guidelines used oral metronidazole as first-line for mild CDI. Current IDSA/SHEA guidelines (and GC lecture framing) prefer oral vancomycin or fidaxomicin as first-line for all severities [1][2]. Metronidazole is now reserved as adjunctive IV therapy in fulminant disease.
- NAAT positivity trap: PCR detects the toxin gene, not active toxin. A positive NAAT in a patient with formed stool = colonisation, not infection. This is a common wrong-answer attractor.
- Pseudomembranous colitis on colonoscopy: Yellow-white adherent plaques that cannot be washed off. This is pathognomonic but not present in all CDI cases.
- C. difficile vs C. perfringens: Both are Gram-positive anaerobic spore-forming bacilli. C. perfringens causes gas gangrene (alpha toxin/lecithinase) and a self-limiting food poisoning (enterotoxin). C. difficile causes antibiotic-associated diarrhoea/pseudomembranous colitis. The clinical scenario discriminates them.
- Fecal microbiota transplantation (FMT): Reserved for multiply recurrent CDI (≥ 2–3 recurrences). This is increasingly tested as a "novel therapy" question.
2021 Fourth Summative SAQ Q12 [3]:
"A 40-year-old man had bone marrow transplant for chronic myeloid leukaemia. ... (b) On day 28 after neutrophil engraftment, he developed fever, impaired liver function test, persistent diarrhoea and chest X-ray infiltrates. The patient admitted that he did not take the antimicrobial prophylaxis which was prescribed. List [four] organisms which may account for his symptoms."
- Correct answer (for diarrhoea component): Clostridioides difficile is a key answer for the persistent diarrhoea in a post-BMT patient (antibiotic exposure is universal in this setting). Other expected answers include CMV (colitis + hepatitis + pneumonitis), Aspergillus (CXR infiltrates), and Pneumocystis jirovecii (if co-trimoxazole prophylaxis not taken). The question tests recognition that CDI must be excluded in any post-chemotherapy/transplant patient with diarrhoea.
No other past paper questions in the indexed context directly and specifically test C. difficile as the primary organism. However, CDI is a plausible differential in several diarrhoea-related stems (e.g., 2019 Minicase Case 1 — traveller with diarrhoea, though enteric fever is the primary answer there).
[1] Lecture slides: GC 099 (Antimicrobial Resistance), GC 102 (Fever After Chemotherapy), GC 104 (Infection Outbreak/Infection Control), GC 106 (Practical Issues in Antibiotic Use), GC 033 (Chronic Diarrhoea/IBD), GC 142 (A Child with Loose Stool), CFB WCS27 (Surgical Infection) [2] AOS material: AOS - Microbio.pdf; Gen Clerk Anaes + Microbiology Summary.pdf [3] Past papers: 2021 Fourth Summative SAQ (2021 Fourth Summative SAQ.pdf), Q12
Bacillus cereus
Gram-positive, spore-forming, aerobic rod that produces emetic and diarrheal enterotoxins, commonly causing food poisoning associated with reheated rice and starchy foods.
Clostridium perfringens
Gram-positive, spore-forming, anaerobic bacillus that produces potent exotoxins (notably alpha-toxin/lecithinase), causing gas gangrene (clostridial myonecrosis) and enterotoxin-mediated food poisoning.